Interleukin-2 as therapy for HIV disease. Dinitrochlorobenzene Study Group
- PMID: 7791830
Interleukin-2 as therapy for HIV disease. Dinitrochlorobenzene Study Group
Comment on
-
Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study.N Engl J Med. 1995 Mar 2;332(9):567-75. doi: 10.1056/NEJM199503023320904. N Engl J Med. 1995. PMID: 7646637 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical